Actusnews Wire - Professional broadcaster of corporate and regulated information, authorised by the AMF and the CSSF.

  BOIRON company press release from 25/01/2018

  25/01/2018 - 17:45

Activity in 2017


(Unaudited data)

  • CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2017
in thousands of euros 2016 2017 Variation at current exchange rates Variation at constant exchange rates
France 370,870 378,487 +2.1% +2.1%
Europe (excluding France) 163,849 155,151 -5.3% -7.3%
North America 64,916 68,572 +5.6% +7.4%
Other countries 14,854 15,330 +3.2% +1.5%
Group total 614,489 617,540 +0.5% +0.1%

in thousands of euros 2016 2017 Variation at current exchange rates Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 313,365 310,594 -0.9% -0.8%
OTC Specialties 299,672 305,552 +2.0% +1.1%
Other 1 452 1 394 -4.0% -4.1%
Group total 614,489 617,540 +0.5% +0.1%
  • QUARTERLY ACTIVITY IN 2017 (variation at current exchange rate)
in thousands of euros 1st quarter 2nd quarter 3rd quarter 4th quarter
2016 2017 Var. 17/16 2016 2017 Var. 17/16 2016 2017 Var. 17/16 2016 2017 Var. 17/16
France 90,494 97,134 +7.3% 80,469 79,328 -1.4% 98,840 101,423 +2.6% 101,067 100,602 -0.5%
Europe (excluding France) 43,685 40,418 -7.5% 31,572 27,421 -13.1% 41,273 42,319 +2.5% 47,319 44,993 -4.9%
North America 16,064 18,179 +13.2% 14,113 14,465 +2.5% 16,020 16,055 +0.2% 18,719 19,873 +6.2%
Other countries 3,846 4,532 +17.8% 4,061 3,191 -21.4% 3,280 4,126 +25.8% 3,667 3,481 -5.1%
Group total 154,089 160,263 +4.0% 130,215 124,405 -4.5% 159,413 163,923 +2.8% 170,772 168,949 -1.1%

in thousands of euros 1st quarter 2nd quarter 3rd quarter 4th quarter
2016 2017 Var. 17/16 2016 2017 Var. 17/16 2016 2017 Var. 17/16 2016 2017 Var. 17/16
Non-proprietary Homeopathic Medicines 80,147 81,016 +1.1% 76,001 74,567 -1.9% 73,913 74,350 +0.6% 83,304 80,661 -3.2%
OTC Specialties 73,743 78,968 +7.1% 53,719 49,391 -8.1% 85,319 89,342 +4.7% 86,891 87,851 +1.1%
Other 199 279 +40.2% 495 447 -9.7% 181 231 +27.6% 577 437 -24.3%
Group total 154,089 160,263 +4.0% 130,215 124,405 -4.5% 159,413 163,923 +2.8% 170,772 168,949 -1.1%

HIGHLIGHTS OF THE FOURTH QUARTER

Sales revenue of the fourth quarter 2017 decreased by 1.1% (-0.4% at constant exchange rates). Sales of non-proprietary homeopathic medicines were down by 3.2%. Sales of OTC specialties were up by 1.1%, with a decrease of 13.3% in Russia and an increase of 2.3% in France and 13.2% in the USA.

Annual sales revenue amounted €617,540 thousand and was stable in comparison to 2016 (+0.5% at current exchange rates and +0.1% at constant exchange rates).

The operating income of 2017 should be lower than in 2016.

 

Our company carries on the development of homeopathy in the world with the same determination.

 


Our next update: March 14, 2018, after the close of the stock market, publication of 2017 results.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com